Reaction
Pruritus Allergic reporting signals
As of the last recalculation, Pruritus Allergic appears in 1,153 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is LEFLUNOMIDE (PRR 22.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Leflunomide | 117 | 22.4 | 22.4 |
| Tofacitinib Citrate | 16 | 22.3 | 22.4 |
| Moxifloxacin Hydrochloride | 23 | 20.9 | 20.9 |
| Desoximetasone | 20 | 19.3 | 19.3 |
| Hydroxychloroquine Sulfate | 66 | 13.8 | 13.8 |
| Adalimumab | 376 | 13.8 | 13.8 |
| Tocilizumab | 77 | 13.0 | 13.0 |
| Sulfasalazine | 53 | 12.8 | 12.8 |
| Cetirizine Hydrochloride Allergy | 21 | 12.7 | 12.7 |
| Cetirizine Hydrochloride Tablets | 21 | 12.7 | 12.7 |
| Abatacept | 82 | 11.4 | 11.4 |
| Vilazodone Hydrochloride | 4 | 7.9 | 7.9 |
| Tofacitinib | 74 | 7.7 | 7.7 |
| Natalizumab | 72 | 7.6 | 7.6 |
| Blinatumomab | 4 | 6.9 | 6.9 |
| Diroximel Fumarate | 3 | 4.6 | 4.6 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 5 | 2.9 | 2.9 |
| Apremilast | 19 | 2.4 | 2.4 |
| Valbenazine | 3 | 2.2 | 2.2 |